Yiwei Chu

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 19

Top Venues

Cell death discovery

Immunotherapy advances

Immunology

Cancer immunology, immunotherapy : CII

Fudan University

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Fudan University

China

Director :: Immunology

Publications

Congwen Li, Congyi Niu, Lin Chen, Baichao Yu, Feifei Luo, Jingbo Qie, Hui Yang, Jiawen Qian, Yiwei Chu
Classical Monocytes Shuttling for Precise Delivery of Nanotherapeutics to Glioblastoma. Advanced healthcare materials (2024)
Peng Chen, Yiwei Chu, Ronghua Liu
Tumour-reactive plasma cells in antitumour immunity: current insights and future prospects. Immunotherapy advances 4 (1) (2024)
Peng Chen, Yiwei Chu, Ronghua Liu
Tumour-reactive plasma cells in antitumour immunity: current insights and future prospects. Immunotherapy advances 4 (1) (2024)
Minxiang Xie, Yuzhen Zhu, Yunjiao Zhou, Qiao Wang, Erli Gu, Yiwei Chu, Luman Wang
Interleukin-35 -producing B cells rescues inflammatory bowel disease in a mouse model via STAT3 phosphorylation and intestinal microbiota modification. Cell death discovery 9 (1) (2023)
Minxiang Xie, Yuzhen Zhu, Yunjiao Zhou, Qiao Wang, Erli Gu, Yiwei Chu, Luman Wang
Interleukin-35 -producing B cells rescues inflammatory bowel disease in a mouse model via STAT3 phosphorylation and intestinal microbiota modification. Cell death discovery 9 (1) (2023)
Minxiang Xie, Yuzhen Zhu, Yunjiao Zhou, Qiao Wang, Erli Gu, Yiwei Chu, Luman Wang
Interleukin-35 -producing B cells rescues inflammatory bowel disease in a mouse model via STAT3 phosphorylation and intestinal microbiota modification. Cell death discovery 9 (1) (2023)
Minxiang Xie, Yuzhen Zhu, Yunjiao Zhou, Qiao Wang, Erli Gu, Yiwei Chu, Luman Wang
Interleukin-35 -producing B cells rescues inflammatory bowel disease in a mouse model via STAT3 phosphorylation and intestinal microbiota modification. Cell death discovery 9 (1) (2023)
Ziwen Zhong, Hao Zhang, Ke Nan, Jing Zhong, Qichao Wu, Lihong Lu, Ying Yue, Zhenyu Zhang, Miaomiao Guo, Zhiqiang Wang, Jie Xia, Yun Xing, Ying Fu, Baichao Yu, Wenchang Zhou, Xingfeng Sun, Yang Shen, Wan-Kun Chen, Jie Zhang, Jin Zhang, Duan Ma, Yiwei Chu, Ronghua Liu, Changhong Miao
Fasting-mimicking diet drives antitumor immunity against colorectal cancer by reducing IgA-producing cells. Cancer research (2023)
Ying Fu, Baichao Yu, Qi Wang, Zhou Lu, Hushan Zhang, Dan Zhang, Feifei Luo, Ronghua Liu, Luman Wang, Yiwei Chu
Oxidative stress-initiated one-carbon metabolism drives the generation of interleukin-10-producing B cells to resolve pneumonia. Cellular & molecular immunology (2023)
Ying Fu, Luman Wang, Baichao Yu, Damo Xu, Yiwei Chu
Immunometabolism shapes B cell fate and functions. Immunology 166 (4) (2022)
Jie Xia, Zhangjuan Xie, Gengming Niu, Zhou Lu, Zhiqiang Wang, Yun Xing, Jun Ren, Zhiqing Hu, Runqi Hong, ZhiPeng Cao, Shanliang Han, Yiwei Chu, Ronghua Liu, Chongwei Ke
Single-cell landscape and clinical outcomes of infiltrating B cells in colorectal cancer. Immunology (2022)
Yuedi Wang, Yiyuan Gao, Congyi Niu, Bo Wang, Shushu Zhao, Gils Roex, Jiawen Qian, Jingbo Qie, Lin Chen, Chenhe Yi, Sébastien Anguille, Jie Liu, Feifei Luo, Yiwei Chu
Chimeric antigen receptor clustering via cysteines enhances T-cell efficacy against tumor. Cancer immunology, immunotherapy : CII 71 (11) (2022)
Yun Xing, Zhiqiang Wang, Zhou Lu, Jie Xia, Zhangjuan Xie, Mengxia Jiao, Ronghua Liu, Yiwei Chu
MicroRNAs: immune modulators in cancer immunotherapy. Immunotherapy advances 1 (1) (2021)
Jiajing Liu, Yifan Li, Zhou Lu, Jie Gu, Yun Liang, Enyu Huang, Zhiming Wang, Hushan Zhang, Luman Wang, Dan Zhang, Hongxiu Yu, Ronghua Liu, Yiwei Chu
Deceleration of glycometabolism impedes IgG-producing B-cell-mediated tumor elimination by targeting SATB1. Immunology 156 (1) (2018)
Yuting Deng, Jiao Yang, Feifei Luo, Jing Qian, Ronghua Liu, Dan Zhang, Hongxiu Yu, Yiwei Chu
mTOR-mediated glycolysis contributes to the enhanced suppressive function of murine tumor-infiltrating monocytic myeloid-derived suppressor cells. Cancer immunology, immunotherapy : CII 67 (9) (2018)
Guojun Qian, Wei Jiang, Benkun Zou, Jintao Feng, Xiaofang Cheng, Jie Gu, Tianqing Chu, Chen Niu, Rui He, Yiwei Chu, Mingfang Lu
LPS inactivation by a host lipase allows lung epithelial cell sensitization for allergic asthma. The Journal of experimental medicine 215 (9) (2018)
Jiawen Qian, Chen Wang, Bo Wang, Jiao Yang, Yuedi Wang, Feifei Luo, Junying Xu, Chujun Zhao, Ronghua Liu, Yiwei Chu
The IFN-γ/PD-L1 axis between T cells and tumor microenvironment: hints for glioma anti-PD-1/PD-L1 therapy. Journal of neuroinflammation 15 (1) (2018)
Jiawen Qian, Feifei Luo, Jiao Yang, Ronghua Liu, Luman Wang, Chen Wang, Yuting Deng, Mingfang Lu, Yuedi Wang, Ji-Yang Wang, Yiwei Chu
TLR2 Promotes Glioma Immune Evasion by Downregulating MHC Class II Molecules in Microglia. Cancer immunology research 6 (10) (2018)
Jiao Yang, Ronghua Liu, Yuting Deng, Jiawen Qian, Zhou Lu, Yuedi Wang, Dan Zhang, Feifei Luo, Yiwei Chu
MiR-15a/16 deficiency enhances anti-tumor immunity of glioma-infiltrating CD8+ T cells through targeting mTOR. International journal of cancer 141 (10) (2017)

Yiwei Chu.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Yiwei Chu